watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
Published 3 years ago • 1.1K plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
5:32
lilly tests covid-19 antibody drug in nursing home facilities
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
3:31
call of the day: eli lilly
-
3:32
dreaming big: the future of mobile research
-
1:41
eli lilly ceo explains supply chain of covid-19 antibody drug
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
4:27
jim cramer on eli lilly's covid-19 phase 2 trial results for antibody drug
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
2:38
eli lilly ceo on drug that could aid covid-19 recovery when paired with remdesivir
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
2:41
eli lilly reports positive phase 3 trial results for covid antibody drug
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
0:39
lilly antibody drug 80% effective at preventing covid-19: nursing home study